Complete Article Index

Every GLP-1 Explained guide,
in one place.

181 evidence-based guides on semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro and Zepbound — organized by topic below. Use the filters or search to find exactly what you need.

181 guides
Drug Comparisons 22 guides
Drug Comparisons
Compounded Semaglutide vs Ozempic/Wegovy: Safety, Efficacy, and the FDA Status (2026)
Drug Comparisons
GLP-1 Agonists vs. Bariatric Surgery: STAMPEDE Trial, Roux-en-Y vs. Sleeve Gastrectomy, Diabetes Remission Rates, and Who Should Choose What
Drug Comparisons
GLP-1 vs Bariatric Surgery: RYGB, Sleeve Gastrectomy & Semaglutide Weight Loss Comparison (2026)
Drug Comparisons
GLP-1 vs Metformin: Head-to-Head Comparison for Type 2 Diabetes and Weight Loss (2026)
Drug Comparisons
Mounjaro vs Ozempic for Type 2 Diabetes: 2024 Head-to-Head Guide
Drug Comparisons
Ozempic vs Wegovy vs Mounjaro vs Zepbound: Complete 2026 Comparison — Doses, Weight Loss, Side Effects
Drug Comparisons
Ozempic vs Wegovy: Same Drug, Different Doses — Complete Semaglutide Comparison 2026
Drug Comparisons
Ozempic vs Wegovy: Same Drug, Different Doses, Different FDA Approvals Explained (2026)
Drug Comparisons
Ozempic vs Wegovy: Same Drug, Different Uses — Which Is Right for You? (2026)
Drug Comparisons
Ozempic vs. Wegovy vs. Mounjaro: Complete Comparison 2026
Drug Comparisons
Saxenda vs Ozempic: Liraglutide vs Semaglutide Full Comparison
Drug Comparisons
Semaglutide vs Liraglutide: Ozempic/Wegovy vs Victoza/Saxenda — Head-to-Head Comparison 2026
Drug Comparisons
Semaglutide vs Tirzepatide: Head-to-Head Evidence (2026)
Drug Comparisons
Tirzepatide vs Semaglutide Head-to-Head: SURMOUNT-5 Trial Results, 20.2% vs 13.7% Weight Loss, Dual GIP/GLP-1 Mechanism, and Which Patients Benefit Most From Each Agent
Drug Comparisons
Tirzepatide vs Semaglutide: Head-to-Head Weight Loss, Side Effects, and Cost (2026)
Drug Comparisons
Tirzepatide vs Semaglutide: Mounjaro vs Wegovy Complete Comparison Guide (2025)
Drug Comparisons
Tirzepatide vs Semaglutide: SURMOUNT-1 (Jastreboff 2022, NEJM, N=2,539, Tirzepatide 15mg −20.9% Body Weight) vs STEP 1 (Wilding 2021, N=1,961, Semaglutide 2.4mg −14.9%), Dual GIP+GLP-1 Agonism vs Mono GLP-1, SURPASS-2 Head-to-Head, and When Each Drug Wins (2026)
Drug Comparisons
Tirzepatide vs Semaglutide: The 2024 Head-to-Head Weight Loss Breakdown
Drug Comparisons
Tirzepatide vs Semaglutide: Weight Loss Comparison — Mounjaro vs Ozempic/Wegovy Guide 2024
Drug Comparisons
Tirzepatide vs Semaglutide: Which Weight Loss Drug Is More Effective? (2026 Clinical Data)
Drug Comparisons
Wegovy vs Zepbound: Semaglutide vs Tirzepatide 2024 Head-to-Head Comparison
Drug Comparisons
Zepbound vs Wegovy: Which GLP-1 Drug Wins for Weight Loss in 2026?
Mental Health & Addiction 15 guides
Mental Health & Addiction
GLP-1 & Binge Eating Disorder: How Semaglutide Silences Food Noise
Mental Health & Addiction
GLP-1 & Food Noise: How Semaglutide Silences Constant Food Thoughts
Mental Health & Addiction
GLP-1 Agonists & Addiction: Dopamine, Alcohol, and the Reward System
Mental Health & Addiction
GLP-1 Agonists & Addiction: Food Noise, Alcohol, Dopamine & Reward Circuitry Explained
Mental Health & Addiction
GLP-1 Agonists and Addiction: GLP-1 Receptors in the Nucleus Accumbens and VTA Suppress Dopamine Reward Signaling, Hendershot 2024 (Alcohol Clin Exp Res) Pilot RCT Shows −40% Alcohol Craving vs Placebo, Jerlhag Mesolimbic Pathway Research, Ozempic for Alcohol/Nicotine/Opioid Craving Reports, and What the "Food Noise" Suppression and Substance Craving Overlap Mean for Addiction Medicine (2026)
Mental Health & Addiction
GLP-1 Drugs and Addiction: The Surprising Evidence on Alcohol, Opioids, and Compulsive Eating
Mental Health & Addiction
GLP-1 Drugs and Alcohol: How Semaglutide Reduces Cravings and the Safety Considerations (2026)
Mental Health & Addiction
GLP-1 Drugs and Alcohol: Why Ozempic Reduces Cravings (The Science)
Mental Health & Addiction
GLP-1 Medications and Alcohol Cravings: The Dopamine Reward Pathway Explained
Mental Health & Addiction
GLP-1 Medications and Alcohol Cravings: Why Semaglutide Reduces Drinking (2026)
Mental Health & Addiction
GLP-1 and Addiction: Alcohol, Tobacco & Binge Eating Reward Circuitry
Mental Health & Addiction
GLP-1 and Addiction: How Semaglutide Is Reducing Alcohol, Smoking, and Compulsive Behaviors Through the Brain's Reward System (2026)
Mental Health & Addiction
GLP-1 and Alcohol Use Disorder: Ghrelin Suppression, Dopamine Reward Circuit Effects, Clinical Evidence for Craving Reduction, and How It Compares to Naltrexone
Mental Health & Addiction
GLP-1 and Mental Health: Depression, Anxiety, and Brain Effects of Semaglutide (2026)
Mental Health & Addiction
GLP-1 and the Brain: Nucleus Accumbens Reward Suppression, Food Noise Elimination, Semaglutide Alcohol Cravings (Klausen 2022 Rodent Data, SELECT Subgroup), Gambling/Shopping Reduction Reports, and the Emerging Addiction Medicine Hypothesis (2026)
Cardiovascular Health 13 guides
Cardiovascular Health
GLP-1 & Cardiovascular Protection: SELECT Trial (N=17,604), LEADER Trial Liraglutide, Atherosclerosis Plaque Regression, −20% MACE
Cardiovascular Health
GLP-1 & Heart Failure: STEP-HFpEF Trial, Semaglutide & HFpEF Explained
Cardiovascular Health
GLP-1 Agonists & the Immune System: Inflammation, Autoimmune Conditions & Cardiovascular Protection
Cardiovascular Health
GLP-1 Agonists and Cardiovascular Outcomes: LEADER, SUSTAIN-6 & Heart Disease Guide
Cardiovascular Health
GLP-1 Cardiovascular Benefits: LEADER Trial, Semaglutide Heart Disease, Atherosclerosis Mechanisms
Cardiovascular Health
GLP-1 Cardiovascular Benefits: The SELECT Trial and Beyond (2026)
Cardiovascular Health
GLP-1 Cardiovascular Outcomes: SELECT Trial −20% MACE, LEADER, SUSTAIN-6, REWIND, STEP-HFpEF Heart Failure Data, and the Direct Cardiac Mechanisms Behind GLP-1 Cardioprotection
Cardiovascular Health
GLP-1 Drugs and Heart Health: Cardiovascular Benefits Beyond Weight Loss (2026)
Cardiovascular Health
GLP-1 and Cardiovascular Disease: SELECT Trial — Semaglutide Reduced MACE by 20% in 17,604 Non-Diabetic Obese Patients, Direct Cardioprotective Mechanisms Beyond Weight Loss, LEADER and SUSTAIN-6 Liraglutide Data, and the GLP-1 Receptor in Myocardium (2026)
Cardiovascular Health
GLP-1 and Cardiovascular Protection: SELECT Trial (−20% MACE in Non-Diabetics), LEADER Trial, and How These Drugs Protect the Heart Beyond Weight Loss (2026)
Cardiovascular Health
GLP-1 and Heart Disease: The SELECT Trial Explained (2026)
Cardiovascular Health
GLP-1 and Heart Health: The SELECT Trial and Cardiovascular Benefits Explained (2026)
Cardiovascular Health
The SELECT Trial: How Semaglutide Became the First Obesity Drug to Prove Cardiovascular Benefit
PCOS & Fertility 13 guides
PCOS & Fertility
GLP-1 Agonists & PCOS: Insulin Resistance, Hormonal Effects & Metabolic Improvement
PCOS & Fertility
GLP-1 Agonists and PCOS: Insulin Resistance, Fertility & Semaglutide Evidence Guide
PCOS & Fertility
GLP-1 Agonists for PCOS: Insulin Resistance Mechanism, Liraglutide Ovulation Data, Androgen Excess Reduction, and the Emerging Fertility Evidence
PCOS & Fertility
GLP-1 Agonists for PCOS: Insulin Resistance, Hormonal Balance & Fertility
PCOS & Fertility
GLP-1 Agonists for PCOS: Insulin Resistance, Weight Loss & Hormonal Benefits
PCOS & Fertility
GLP-1 Agonists, Male Fertility & Testosterone: The Obesity-Hypogonadism Connection
PCOS & Fertility
GLP-1 Drugs for PCOS: Semaglutide, Weight Loss, and Insulin Resistance (2026)
PCOS & Fertility
GLP-1 Drugs for PCOS: Weight Loss, Insulin Resistance, and Androgen Reduction (2026)
PCOS & Fertility
GLP-1 and PCOS: Insulin Resistance as the Core Driver, Semaglutide Weight Loss Restoring Menstrual Cycles, Testosterone Reduction, Tirzepatide SURMOUNT-PCOS Data, Comparison With Metformin, and the Evidence-Based Protocol for GLP-1 in Polycystic Ovary Syndrome (2026)
PCOS & Fertility
GLP-1 and PCOS: Insulin Resistance, Semaglutide Off-Label, and What the Evidence Shows (2026)
PCOS & Fertility
GLP-1 for PCOS: Weight Loss, Insulin Resistance, and Fertility Outcomes (2026)
PCOS & Fertility
GLP-1 for PCOS: Why Endocrinologists Are Increasingly Prescribing Semaglutide Off-Label
PCOS & Fertility
Semaglutide and Male Fertility: What GLP-1 Drugs Do to Testosterone and Sperm
Weight Loss Plateau, Regain & Long-Term Use 13 guides
Weight Loss Plateau, Regain & Long-Term Use
Breaking a GLP-1 Weight Loss Plateau: The Complete Guide
Weight Loss Plateau, Regain & Long-Term Use
GLP-1 Weight Loss Plateau: Science-Backed Strategies to Break Through
Weight Loss Plateau, Regain & Long-Term Use
GLP-1 Weight Loss Plateau: Why It Happens and Evidence-Based Strategies to Break Through (2026)
Weight Loss Plateau, Regain & Long-Term Use
GLP-1 Weight Loss Plateau: Why It Happens and What to Do (2026)
Weight Loss Plateau, Regain & Long-Term Use
GLP-1 Weight Regain: What Happens When You Stop Ozempic or Wegovy (2026)
Weight Loss Plateau, Regain & Long-Term Use
GLP-1 as Chronic Disease Treatment: Long-Term Maintenance, STEP 4 Data & Indefinite Use Guide
Weight Loss Plateau, Regain & Long-Term Use
Ozempic Plateau: Why Weight Loss Stalls on GLP-1 Drugs and What to Do (2026)
Weight Loss Plateau, Regain & Long-Term Use
Ozempic Plateau: Why Weight Loss Stalls on GLP-1 and What to Do (2026)
Weight Loss Plateau, Regain & Long-Term Use
Stopping GLP-1 Medications: Managing Weight Regain After Ozempic or Wegovy (2026)
Weight Loss Plateau, Regain & Long-Term Use
Stopping Ozempic: Weight Regain, Rebound, and What the Evidence Shows (2026)
Weight Loss Plateau, Regain & Long-Term Use
What Happens When You Stop GLP-1 Medications
Weight Loss Plateau, Regain & Long-Term Use
What Happens When You Stop GLP-1 — Weight Rebound, Appetite Return & Discontinuation Strategy
Weight Loss Plateau, Regain & Long-Term Use
What Happens When You Stop Ozempic or Wegovy: Weight Regain, Timeline, and Prevention (2026)
Side Effects & Safety 13 guides
Side Effects & Safety
GLP-1 Drugs and Eye Health: NAION Vision Risk, the 2024 Study & What the Evidence Actually Shows
Side Effects & Safety
GLP-1 Agonists & Gut Motility: Gastroparesis, Gastric Emptying & Anesthesia Guide
Side Effects & Safety
GLP-1 Injection Technique: Site Rotation, Needle Length & Side Effect Management
Side Effects & Safety
GLP-1 Nausea: Why It Happens & Evidence-Based Management Tips
Side Effects & Safety
GLP-1 Safety Risks: Pancreatitis, Thyroid Cancer & Gallbladder Disease — Evidence Guide
Side Effects & Safety
GLP-1 Side Effects: How to Manage Nausea, Vomiting, and Constipation (2026)
Side Effects & Safety
GLP-1 Side Effects: Nausea, Gastroparesis, Pancreatitis Risk, and How to Manage Them (2026)
Side Effects & Safety
GLP-1 Side Effects: Nausea, Vomiting & Dose Escalation Guide
Side Effects & Safety
GLP-1 Side Effects: Nausea, Vomiting, GERD — Why They Happen and How to Minimize Them (2026)
Side Effects & Safety
GLP-1 Side Effects: What's Real, What's Overblown
Side Effects & Safety
Ozempic & Wegovy Side Effects: What to Expect, What to Do (2026)
Side Effects & Safety
Ozempic Side Effects: Nausea, Vomiting, Gastroparesis — How to Manage Them (2026)
Side Effects & Safety
Ozempic and Semaglutide Side Effects: Nausea Management, Muscle Loss, and Long-Term Safety (2026)
Muscle Preservation & Exercise 10 guides
Muscle Preservation & Exercise
Does Ozempic Cause Muscle Loss? GLP-1 Agonists and Lean Mass (2026)
Muscle Preservation & Exercise
Exercise on GLP-1: Resistance Training Guide to Preserve Muscle
Muscle Preservation & Exercise
GLP-1 & Muscle Loss: How to Protect Lean Mass on Semaglutide or Tirzepatide
Muscle Preservation & Exercise
GLP-1 Weight Loss Plateau: Muscle Preservation, Protein & Resistance Training Guide
Muscle Preservation & Exercise
GLP-1 and Muscle Loss: How to Preserve Lean Mass During Weight Loss
Muscle Preservation & Exercise
GLP-1 and Muscle Loss: How to Preserve Lean Mass on Semaglutide or Tirzepatide (2026)
Muscle Preservation & Exercise
GLP-1 and Muscle Loss: What to Eat to Protect Lean Mass
Muscle Preservation & Exercise
Muscle Loss on GLP-1 Medications: How to Prevent It
Muscle Preservation & Exercise
Preventing Muscle Loss on GLP-1 Drugs: The Complete Protocol
Muscle Preservation & Exercise
Preventing Muscle Loss on GLP-1 Medications: Complete Guide to Lean Mass Preservation
Diabetes & Insulin Resistance 9 guides
Diabetes & Insulin Resistance
GLP-1 Agonists & Metabolic Syndrome: Visceral Fat, Insulin Resistance & Cardiometabolic Risk
Diabetes & Insulin Resistance
GLP-1 Agonists & Type 2 Diabetes Remission: HbA1c, Beta Cell Preservation & Clinical Data
Diabetes & Insulin Resistance
GLP-1 Agonists in Type 1 Diabetes: Off-Label Use as Insulin Adjunct — Weight Loss, A1c, & Risks
Diabetes & Insulin Resistance
GLP-1 Medications and Type 2 Diabetes: HbA1c Reduction, Beta Cell Preservation & Remission Evidence
Diabetes & Insulin Resistance
GLP-1 and Type 2 Diabetes: SUSTAIN Trials (Semaglutide −1.5–1.8% HbA1c), SURPASS Program (Tirzepatide −2.1% HbA1c, 40% Reaching Normal Glucose), Beta-Cell Preservation, T2D Remission, and Why GLP-1 Drugs Are Now First-Line in T2D With CVD (2026)
Diabetes & Insulin Resistance
GLP-1 for Insulin Resistance and Type 2 Diabetes: Beyond Weight Loss (2026)
Diabetes & Insulin Resistance
Insulin Resistance and Metabolic Syndrome: Root Causes, Biomarkers, and Reversal (2026)
Diabetes & Insulin Resistance
Insulin Resistance: The Cellular Mechanisms Behind Type 2 Diabetes and How GLP-1 Agonists Reverse It (2026)
Diabetes & Insulin Resistance
Type 2 Diabetes Remission With GLP-1 and GIP/GLP-1 Agonists: SUSTAIN Trials, Tirzepatide Superiority (2026)
Kidney & Renal Health 8 guides
Kidney & Renal Health
GLP-1 Agonists and Kidney Disease: FLOW Trial, CKD Protection & Dosing Guide
Kidney & Renal Health
GLP-1 Agonists and Kidney Protection: FLOW Trial, CKD & Diabetic Nephropathy Guide
Kidney & Renal Health
GLP-1 Drugs and Kidney Health: FLOW Trial Results and Renal Protection (2026)
Kidney & Renal Health
GLP-1 Kidney Protection: FLOW Trial, Diabetic Nephropathy & Renal Mechanisms
Kidney & Renal Health
GLP-1 and Kidney Disease: FLOW Trial (Perkovic 2024, NEJM, N=3,533, −24% Kidney+CV Events with Semaglutide), Renal Protection Mechanisms, GLP-1 vs SGLT2 Inhibitors for CKD, eGFR Trajectory, and First-Line Guidelines for T2DM with CKD (2026)
Kidney & Renal Health
GLP-1 and Kidney Disease: FLOW Trial Semaglutide in CKD, eGFR Slope Improvement, Proteinuria Reduction, Cardiorenal Syndrome Mechanisms, and UACR as Renal Biomarker
Kidney & Renal Health
GLP-1 and Kidney Protection: CREDENCE and DAPA-CKD Trial Data, GLP-1 vs SGLT2 Inhibitor Renal Mechanisms, Intraglomerular Pressure, and Who Should Get Which Drug
Kidney & Renal Health
Semaglutide and Kidney Disease: The FLOW Trial Results Explained
Cost, Insurance & Access 7 guides
Cost, Insurance & Access
Find a GLP-1 Provider — Telehealth Comparison 2026
Cost, Insurance & Access
GLP-1 Cost & Insurance Coverage: The Complete Guide (2025)
Cost, Insurance & Access
GLP-1 Drugs for Non-Diabetics: Who Qualifies, Costs, and What the Evidence Shows (2026)
Cost, Insurance & Access
GLP-1 Insurance Coverage & Cost Guide 2024: Prior Auth, Savings Cards & Compounding
Cost, Insurance & Access
GLP-1 Medication Cost & Insurance Coverage Guide 2026
Cost, Insurance & Access
How to Get Insurance to Cover GLP-1 Drugs: Prior Auth, Appeals & Insurer Guide
Cost, Insurance & Access
Wegovy Insurance Coverage Guide 2026
Liver Health (NAFLD / MASH) 7 guides
Liver Health (NAFLD / MASH)
GLP-1 Agonists for Fatty Liver Disease (MASH/NAFLD): What the Trials Show (2026)
Liver Health (NAFLD / MASH)
GLP-1 Agonists for NAFLD & NASH: Semaglutide, Liver Fat Reduction & Fibrosis Guide
Liver Health (NAFLD / MASH)
GLP-1 Drugs and Fatty Liver (MASLD/NAFLD): What the Trial Data Shows (2026)
Liver Health (NAFLD / MASH)
GLP-1 and Fatty Liver Disease (MASH/MASLD): ESSENCE Trial (Newsome 2024, NEJM, N=800 — 62.9% vs 18.6% NASH Resolution with Semaglutide 2.4mg), GLP-1 Mechanisms in Hepatic Steatosis, Fibrosis Regression, ALT Normalization, Comparison with Resmetirom (Rezdiffra), and Updated AASLD/ADA Guidelines for MASH Treatment (2026)
Liver Health (NAFLD / MASH)
GLP-1 and NAFLD/NASH: SURMOUNT-NASH Tirzepatide 2024 Data, Hepatic Fat Reduction, Liver Fibrosis Improvement, and ALT Normalization
Liver Health (NAFLD / MASH)
GLP-1 for Fatty Liver (MASLD/NASH): Semaglutide and Tirzepatide Evidence (2026)
Liver Health (NAFLD / MASH)
Semaglutide for Fatty Liver Disease: The MASH Trials That Are Reshaping Hepatology
Sleep & Sleep Apnea 7 guides
Sleep & Sleep Apnea
GLP-1 & Sleep Apnea: SURMOUNT-OSA Trial, Tirzepatide AHI Reduction 63%, Semaglutide OSA Data, vs. CPAP
Sleep & Sleep Apnea
GLP-1 Agonists and Sleep: Sleep Apnea, Circadian Rhythm & Melatonin Guide
Sleep & Sleep Apnea
GLP-1 Drugs and Sleep: How Semaglutide and Tirzepatide Affect Sleep Quality (2026)
Sleep & Sleep Apnea
GLP-1 Medications and Sleep Quality: The Sleep Apnea Breakthrough
Sleep & Sleep Apnea
GLP-1 and Sleep Apnea: SURMOUNT-OSA Tirzepatide 2024 Trial, −62.8% AHI Reduction, Pharyngeal Fat Mechanism, Hypoxic Burden Improvement, and Whether GLP-1 RAs Can Replace CPAP
Sleep & Sleep Apnea
GLP-1 and Sleep Apnea: SURMOUNT-OSA Trial — Tirzepatide Reduced AHI by 55–63%, SCALE Sleep Liraglutide, Upper Airway Fat Mechanism, and Why GLP-1 Drugs May Replace CPAP for Obese OSA Patients (2026)
Sleep & Sleep Apnea
GLP-1 and Sleep Apnea: SURMOUNT-OSA Trial, Tirzepatide AHI Reduction, Upper Airway Fat Mechanism, and Whether GLP-1s Can Replace CPAP
Diet & Nutrition 6 guides
Diet & Nutrition
Best Foods to Eat on GLP-1 Drugs: Nutrition Guide for Ozempic and Wegovy (2026)
Diet & Nutrition
Best Foods to Eat on GLP-1 Drugs: Protein, Muscle Loss, and What the Science Says
Diet & Nutrition
Best Foods to Eat on GLP-1 Drugs: Protein, Muscle Loss, and What the Science Says
Diet & Nutrition
Best Foods to Eat on Ozempic and Wegovy (2026)
Diet & Nutrition
Foods That Boost Natural GLP-1: Dietary Strategies to Enhance Satiety (2026)
Diet & Nutrition
GLP-1 Supplements That Actually Work (And the Ones That Don't)
Skin, Hair & Aging 5 guides
Skin, Hair & Aging
GLP-1 Drugs & Skin/Hair Changes: Telogen Effluvium, Collagen Loss & What To Do
Skin, Hair & Aging
GLP-1 Hair Loss Guide: Telogen Effluvium, Nutrient Deficiencies & Prevention
Skin, Hair & Aging
GLP-1 and Hair Loss: Is Ozempic Causing Telogen Effluvium? (2026)
Skin, Hair & Aging
Ozempic Face: Facial Aging on GLP-1 Weight Loss Drugs — What's Real (2026)
Skin, Hair & Aging
Semaglutide Hair Loss and Skin Changes: What's Actually Happening and What to Do
Buyer's Guides 12 guides
Buyer's Guides
Best Hair Loss & Regrowth Products for GLP-1 Users (2026)
Buyer's Guides
Best Resistance Bands & Home Strength Equipment for GLP-1 Users (2026)
Buyer's Guides
Best Electrolyte & Fiber Supplements for GLP-1 Users (2026)
Buyer's Guides
Best Foods to Eat on GLP-1 Medications (2025 Buyer's Guide)
Buyer's Guides
Best GLP-1 Telehealth Providers Compared: SkinnyRx vs MEDVi vs Elevate Health (2026)
Buyer's Guides
Best Protein Powder for GLP-1 & Ozempic Users (2026)
Buyer's Guides
Best Multivitamins for GLP-1 & Ozempic Users (2026)
Buyer's Guides
Best Anti-Nausea Remedies for Ozempic & Wegovy Users (2026)
Buyer's Guides
Best CGM (Continuous Glucose Monitor) for GLP-1 Users (2026)
Buyer's Guides
Best Meal Replacement Shakes for GLP-1 Users (2026)
Buyer's Guides
Best Travel & Cooling Cases for GLP-1 Pens (2026)
Buyer's Guides
Best Heartburn & Acid Reflux Remedies for GLP-1 Users (2026)
Brain Health & Alzheimer's 4 guides
Brain Health & Alzheimer's
GLP-1 & Alzheimer's Disease: Hölscher 2012 Neuroprotection, Semaglutide LIBRA Trial, GLP-1R in Hippocampus, BDNF Upregulation
Brain Health & Alzheimer's
GLP-1 Agonists & Alzheimer's Disease: Liraglutide ELAD Trial, Semaglutide Norgaard 2024 JAMA, EVOKE Trial, Type 3 Diabetes, Neuroinflammation
Brain Health & Alzheimer's
GLP-1 and Alzheimer's: Why Neurologists Are Watching Semaglutide With Extraordinary Interest
Brain Health & Alzheimer's
GLP-1 and the Brain: Alzheimer's Risk Reduction, Parkinson's Neuroprotection, and SUSTAIN-6 Stroke Data (2026)
Bone Health 3 guides
Bone Health
GLP-1 & Bone Health: Osteoporosis Risk, Fracture Studies & Protection Guide (2024)
Bone Health
GLP-1 and Bone Density: GIP Receptor Biology, Bone Turnover Markers, Semaglutide Fracture Data, and Why Tirzepatide's Dual GIP/GLP-1 Action Matters for Skeletal Health
Bone Health
Semaglutide and Bone Health: What the Research Actually Shows About Fracture Risk
How It Works & Mechanism 3 guides
How It Works & Mechanism
How GLP-1 Medications Work — The Science Explained
How It Works & Mechanism
Semaglutide vs Tirzepatide Weight Loss: STEP 1 (−14.9%), SURMOUNT-1 (−20.9%), GLP-1 + GIP Dual Agonism, Gastric Emptying, Central Appetite Suppression — Complete Mechanism Guide (2026)
How It Works & Mechanism
The GLP-1 Starter Guide
Drug Profiles & Formulations 3 guides
Drug Profiles & Formulations
Oral Semaglutide (Rybelsus) vs Ozempic: Bioavailability, Absorption & PIONEER Trials
Drug Profiles & Formulations
Rybelsus (Oral Semaglutide): The Pill Form of Ozempic — What the Science Actually Says
Drug Profiles & Formulations
Tirzepatide (Mounjaro vs Zepbound): Dual GLP-1/GIP Agonist — Complete Evidence Review (2026)
Next-Gen & Emerging Drugs 3 guides
Next-Gen & Emerging Drugs
Retatrutide & Next-Gen GLP-1 Agonists: Triple Agonist Science, Pipeline & 2026–2028 FDA Timeline
Next-Gen & Emerging Drugs
Retatrutide (LY3437943): The Triple Agonist That Outperformed Every GLP-1 Drug
Next-Gen & Emerging Drugs
Retatrutide and the Next-Gen GLP-1 Drugs: Triple Agonists Explained
Dosing & Injection Technique 2 guides
Dosing & Injection Technique
GLP-1 Dosing Titration Guide: Semaglutide and Tirzepatide Schedules (2026)
Dosing & Injection Technique
GLP-1 Injection Technique, Pen Storage & Titration Guide
Pregnancy & Pediatric Use 2 guides
Pregnancy & Pediatric Use
GLP-1 Agonists and Pregnancy: Fertility, Discontinuation Timing & Gestational Diabetes Guide
Pregnancy & Pediatric Use
GLP-1 Agonists for Pediatric & Adolescent Obesity: Semaglutide & Tirzepatide Guide 2024
Tools & Quizzes 1 guides
Tools & Quizzes
Are You a Candidate for GLP-1 Medications? — Free Quiz
Losing weight? Don't lose muscle.
Up to 40% of GLP-1 weight loss can be muscle. The GLP-1 Protein Playbook shows you exactly how to protect it — with 25 high-protein meals that go down easy on a killed appetite.
Get the Playbook → $19